Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer’s Patients
The disorder of Alzheimer’s is marked by progressive pathophysiological neurodegeneration. The amino acid peptides in the amyloid plaques found in the brains of people with Alzheimer’s disease (AD) are known as amyloid-beta (Aβ). Current treatments are not curative, and the effects associated with A...
Main Author: | Mohamed Abbas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/13/7/1051 |
Similar Items
-
BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01) -
A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles
by: Xing Y, et al.
Published: (2017-04-01) -
Designed Cell-Penetrating Peptide Inhibitors of Amyloid-beta Aggregation and Cytotoxicity
by: Anja Henning-Knechtel, et al.
Published: (2020-02-01) -
Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01) -
Progress in the study of the correlation between cerebral amyloid angiopathy and Alzheimer's disease
by: LU Zheng⁃qi, et al.
Published: (2021-10-01)